COMMUNIQUÉS West-GlobeNewswire
-
Correction: IPSEN - Buy-back programme - Art 5 of MAR - Week 36- 2026
15/09/2026 -
Correction: IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 36 - 2026
15/09/2026 -
Elevar Therapeutics Submits Marketing Authorization Application to European Medicines Agency for Lirafugratinib as a Treatment for Patients with Advanced/Metastatic Cholangiocarcinoma (CCA) Harboring FGFR2 Fusions or Rearrangements
15/09/2026 -
FemPulse Clinical Data to be Presented at ICS on October 9
15/09/2026 -
USAHS Brings Healthcare Professionals Together to Spark Action on Workplace Mental Health
15/09/2026 -
Patterson Veterinary Launches Atlas: an AI Assistant for Veterinary Software
15/09/2026 -
FDA Launches Expedited IND Pilot, Begins Accepting Applications
15/09/2026 -
AscellaHealth Advances AscellaOne Technology Strategy, Names Asad Shoostry Chief Technology Officer
15/09/2026 -
Lanier Recovery Center earns Joint Commission accreditation
15/09/2026 -
AliveCor Launches KardiaACCESS: A Medicare-Covered Program Built to Improve Blood Pressure, Diabetes, and Heart Health
15/09/2026 -
Le KFSH de Riyad ne relève aucun constat à haut risque sur près de 1 800 critères évalués lors du renouvellement de son accréditation JCI
15/09/2026 -
Investor Determination to Beat Cancer Puts NeOnc’s Novel Therapies and Patented Platform in Focus
15/09/2026 -
Ally Medical ER Collects More Than 16,000 Items for Texas Shelter Pets
15/09/2026 -
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
15/09/2026 -
GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma
15/09/2026 -
AMA and Atalan Launch Collaboration to Advance Physician Retention Research
15/09/2026 -
Touro University Awards Shlomo Rechnitz Honorary Doctorate for Contributions to Healthcare and Philanthropy
15/09/2026 -
Nice Healthcare Supports Employers with Launch of New Health Plan
15/09/2026 -
Applied Biologics Launches APPB-429 Gene Therapy Program for Diabetic Peripheral Neuropathy
15/09/2026
Pages